1 |
Villalobos A, Wagstaff W, Guo M, Zhang J, Bercu Z, Whitmore MJ, Cristescu MM, Majdalany BS, Wedd J, Akce M, Magliocca J, Kokabi N. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma. Can J Gastroenterol Hepatol 2021;2021:9926704. [PMID: 34336728 DOI: 10.1155/2021/9926704] [Reference Citation Analysis]
|
2 |
Seager MJ. Radiation Segmentectomy for Small, Solitary Hepatocellular Carcinoma. Radiol Imaging Cancer 2021;3:e219006. [PMID: 33817658 DOI: 10.1148/rycan.2021219006] [Reference Citation Analysis]
|
3 |
Gordon AC, Lewandowski RJ. CBCT-guided TACE-MWA for HCC Measuring up to 5 cm. Acad Radiol 2021:S1076-6332(21)00227-0. [PMID: 34154903 DOI: 10.1016/j.acra.2021.05.012] [Reference Citation Analysis]
|
4 |
De la Garza-Ramos C, Overfield CJ, Montazeri SA, Liou H, Paz-Fumagalli R, Frey GT, McKinney JM, Ritchie CA, Devcic Z, Lewis AR, Harnois DM, Patel T, Toskich BB. Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated. J Hepatocell Carcinoma 2021;8:861-70. [PMID: 34368021 DOI: 10.2147/JHC.S319215] [Reference Citation Analysis]
|